| Protein | Synonyms | Taxonomy |
|---|
| E3 ubiquitin-protein ligase parkin | Parkin; EC 2.3.2.31; Parkin RBR E3 ubiquitin-protein ligase; Parkinson juvenile disease protein 2; Parkinson disease protein 2 | Homo sapiens (human) |
| Flotillin-1 | | Homo sapiens (human) |
| Cellular tumor antigen p53 | Antigen NY-CO-13; Phosphoprotein p53; Tumor suppressor p53 | Homo sapiens (human) |
| Heat shock protein HSP 90-alpha | EC 3.6.4.10; Heat shock 86 kDa; HSP 86; HSP86; Lipopolysaccharide-associated protein 2; LAP-2; LPS-associated protein 2; Renal carcinoma antigen NY-REN-38 | Homo sapiens (human) |
| Neutrophil elastase | EC 3.4.21.37; Bone marrow serine protease; Elastase-2; Human leukocyte elastase; HLE; Medullasin; PMN elastase | Homo sapiens (human) |
| Caspase-8 | CASP-8; EC 3.4.22.61; Apoptotic cysteine protease; Apoptotic protease Mch-5; CAP4; FADD-homologous ICE/ced-3-like protease; FADD-like ICE; FLICE; ICE-like apoptotic protease 5; MORT1-associated ced-3 homolog; MACH | Homo sapiens (human) |
| Non-structural protein 1 | NS1; NS1A | Influenza A virus (A/Puerto Rico/8/1934(H1N1)) |
| Granzyme B | EC 3.4.21.79; C11; CTLA-1; Cathepsin G-like 1; CTSGL1; Cytotoxic T-lymphocyte proteinase 2; Lymphocyte protease; Fragmentin-2; Granzyme-2; Human lymphocyte protein; HLP; SECT; T-cell serine protease 1-3E | Homo sapiens (human) |
| Caspase-1 | CASP-1; EC 3.4.22.36; Interleukin-1 beta convertase; IL-1BC; Interleukin-1 beta-converting enzyme; ICE; IL-1 beta-converting enzyme; p45 | Homo sapiens (human) |
| Caspase-3 | CASP-3; EC 3.4.22.56; Apopain; Cysteine protease CPP32; CPP-32; Protein Yama; SREBP cleavage activity 1; SCA-1 | Homo sapiens (human) |
| Apoptosis regulator BAX | Bcl-2-like protein 4; Bcl2-L-4 | Homo sapiens (human) |
| Receptor-interacting serine/threonine-protein kinase 1 | EC 2.7.11.1; Cell death protein RIP; Receptor-interacting protein 1; RIP-1 | Homo sapiens (human) |
| E3 ubiquitin-protein ligase Itchy homolog | Itch; EC 2.3.2.26; Atrophin-1-interacting protein 4; AIP4; HECT-type E3 ubiquitin transferase Itchy homolog; NFE2-associated polypeptide 1; NAPP1 | Homo sapiens (human) |
| Ribonucleoside-diphosphate reductase large subunit | R1; EC 1.17.4.1; Ribonucleotide reductase large subunit | Human alphaherpesvirus 1 strain 17 |
| Bcl-2 homologous antagonist/killer | Apoptosis regulator BAK; Bcl-2-like protein 7; Bcl2-L-7 | Homo sapiens (human) |
| Mixed lineage kinase domain-like protein | hMLKL | Homo sapiens (human) |
| Cytochrome c | | Homo sapiens (human) |
| Receptor-interacting serine/threonine-protein kinase 3 | EC 2.7.11.1; RIP-like protein kinase 3; Receptor-interacting protein 3; RIP-3 | Homo sapiens (human) |
| Syntenin-1 | Melanoma differentiation-associated protein 9; MDA-9; Pro-TGF-alpha cytoplasmic domain-interacting protein 18; TACIP18; Scaffold protein Pbp1; Syndecan-binding protein 1 | Homo sapiens (human) |
| Gasdermin-D | Gasdermin domain-containing protein 1 | Homo sapiens (human) |
| High mobility group protein B1 | High mobility group protein 1; HMG-1 | Homo sapiens (human) |
| Hsp90 co-chaperone Cdc37 | Hsp90 chaperone protein kinase-targeting subunit; p50Cdc37 | Homo sapiens (human) |
| TNF receptor-associated factor 2 | EC 2.3.2.27; E3 ubiquitin-protein ligase TRAF2; RING-type E3 ubiquitin transferase TRAF2; Tumor necrosis factor type 2 receptor-associated protein 3 | Homo sapiens (human) |
| FAS-associated death domain protein | FAS-associating death domain-containing protein; Growth-inhibiting gene 3 protein; Mediator of receptor induced toxicity; Protein FADD | Homo sapiens (human) |
| Tumor protein 63 | p63; Chronic ulcerative stomatitis protein; CUSP; Keratinocyte transcription factor KET; Transformation-related protein 63; TP63; Tumor protein p73-like; p73L; p40; p51 | Homo sapiens (human) |
| Ubiquitin-conjugating enzyme E2 L3 | EC 2.3.2.23; E2 ubiquitin-conjugating enzyme L3; L-UBC; UbcH7; Ubiquitin carrier protein L3; Ubiquitin-conjugating enzyme E2-F1; Ubiquitin-protein ligase L3 | Homo sapiens (human) |
| UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit | EC 2.4.1.255; O-GlcNAc transferase subunit p110; O-linked N-acetylglucosamine transferase 110 kDa subunit; OGT | Homo sapiens (human) |
| Charged multivesicular body protein 6 | Chromatin-modifying protein 6; Vacuolar protein sorting-associated protein 20; Vps20; hVps20 | Homo sapiens (human) |
| E3 ubiquitin-protein ligase CHIP | EC 2.3.2.27; Antigen NY-CO-7; CLL-associated antigen KW-8; Carboxy terminus of Hsp70-interacting protein; RING-type E3 ubiquitin transferase CHIP; STIP1 homology and U box-containing protein 1 | Homo sapiens (human) |
| Gasdermin-E | Inversely correlated with estrogen receptor expression 1; ICERE-1; Non-syndromic hearing impairment protein 5 | Homo sapiens (human) |
| Flotillin-2 | Epidermal surface antigen; ESA; Membrane component chromosome 17 surface marker 1 | Homo sapiens (human) |
| Tumor necrosis factor receptor type 1-associated DEATH domain protein | TNFR1-associated DEATH domain protein; TNFRSF1A-associated via death domain | Homo sapiens (human) |
| Programmed cell death 6-interacting protein | PDCD6-interacting protein; ALG-2-interacting protein 1; ALG-2-interacting protein X; Hp95 | Homo sapiens (human) |
| Charged multivesicular body protein 7 | Chromatin-modifying protein 7 | Homo sapiens (human) |
| E3 ubiquitin-protein ligase pellino homolog 1 | Pellino-1; EC 2.3.2.27; Pellino-related intracellular-signaling molecule; RING-type E3 ubiquitin transferase pellino homolog 1 | Homo sapiens (human) |
| Charged multivesicular body protein 3 | Chromatin-modifying protein 3; Neuroendocrine differentiation factor; Vacuolar protein sorting-associated protein 24; hVps24 | Homo sapiens (human) |
| Compound | Description |
|---|
| uridine diphosphate | A uracil nucleotide containing a pyrophosphate group esterified to C5 of the sugar moiety. |
| disulfiram | A carbamate derivative used as an alcohol deterrent. It is a relatively nontoxic substance when administered alone, but markedly alters the intermediary metabolism of alcohol. When alcohol is ingested after administration of disulfiram, blood acetaldehyde concentrations are increased, followed by flushing, systemic vasodilation, respiratory difficulties, nausea, hypotension, and other symptoms (acetaldehyde syndrome). It acts by inhibiting aldehyde dehydrogenase. |
| adenosine diphosphate | Adenosine 5'-(trihydrogen diphosphate). An adenine nucleotide containing two phosphate groups esterified to the sugar moiety at the 5'-position. |
| ditiocarb | A chelating agent that has been used to mobilize toxic metals from the tissues of humans and experimental animals. It is the main metabolite of DISULFIRAM. |
| adenosine triphosphate | An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter. |
| myo-inositol 1,3,4,5,6-pentakisphosphate | |
| inositol-1,3,4,6-tetrakisphosphate | for cpd without numerical locants of phosphate groups, index INOSITOL PHOSPHATES |